Cardiovascular risk and comorbid conditions among black South Africans with hypertension in public and private primary care settings: The HiHi study

Ethnicity and Disease

Volumn 17, Issue 3, 2007, Pages 477-483

  Dennison, Cheryl R ^a,d   Peer, Nasheeta ^b   Lombard, Carl J ^b   Kepe, Lulama ^b   Levitt, Naomi S ^b,c   Steyn, Krisela ^b,c   Hill, Martha N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF NURSING   (United States)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Blacks; Cardiovascular risk; Ethnicity; Health disparities; Hypertension; South Africa

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METHYLDOPA; RESERPINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; COMORBIDITY; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT CARE; PRIMARY MEDICAL CARE; RISK FACTOR; RISK MANAGEMENT; SELF REPORT; SMOKING; SOUTH AFRICA; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH BEHAVIOR; HEALTH STATUS DISPARITIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PRIVATE SECTOR; PUBLIC SECTOR; RISK FACTORS; SOUTH AFRICA;

EID: 35348984104     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Nelson RG, Knowler WC, Pettitt DJ, Saad MF, Charles MA, Bennett PH. Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens. Arch Intern Med. 1991;151:1761-1765.
2. Grundy SM, Pasternack R, Greenland P, Smith S, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999;100:1481-1492.
3. Jackson R. Updated New Zealand cardiovascular disease risk-benefit prediction guide. BMJ. 2000;320:709-710.
4. Berger G, Marais AD. Diagnoses, Management and Prevention of the Common Dyslipidemias in South Africa - Clinical Guideline 2000 South African Medical Association and LASSA Working Group; 2000.
5. Green LW, Kreuter MW. Health Program Planning: An Educational and Ecological Approach, 4th Edition. New York: McGraw-Hill; 2005.
6. Dennison CR, Peer N, Steyn K, Hill MN. Determinants of hypertension control among Peri-urban Black South Africans in treatment: The HiHi Study. Ethn Dis. 2007;17(3):484-491.
7. Gandek B, Ware JE. Methods for Validating and Norming Translations of Health Status Questionnaires: The IQOLA Project Approach. J Clin Epidemiol. 1998;51(11):953-959.
8. Lambert EV, Steyn K, Stender S, Everage N, Fourie JM, Hill M. Cross-cultural validation of the Hill-Bone compliance to high blood pressure therapy scale in a South African, primary health care setting. Ethn Dis. 2006;16:286-291.
9. Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA. 1984;252:1905.
10. Global Physical Activity Questionnaire (GPAQ). World Health Organization. Department of Chronic Disease and Health Promotion. Available: http://www.who.int/chp/steps/GPAQ/en/print.html. Last accessed: 6/5/2006.
11. Bray GA. Definition, measurement, and classification of the syndromes of obesity. Int J Obesity. 1978;2:499-502.
12. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code manual of electrocardiographic findings. Boston, Mass: John Wright, PGS; 1982.
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
14. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
15. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293-298.
16. Anatomical Therapeutic Chemical Classification (ATC) Index with Defined Daily Doses (DDDs). WHO Collaborating Centre for Drugs. Norway: Statistical Methodology; 1998.
17. Steyn K, Sliwa-Hahnle K, Hawkens S, et al. Risk factors associated with myocardial infarction in Africa. The INTERHEART Africa Study. Circulation. 2005;112(23):3554-61.
18. Puoane T, Steyn K, Bradshaw D, Laubscher R, Fourie JM, Lambert V, Mbananga N. Obesity in South Africa: the South African demographic and health survey. Obes Res. 2002;10(10):1038-1048.
19. Levitt NS, Katzenellenbogen JM, Bradshaw D, Hoffman MN, Bonnici F. The prevalence and identification of risk factors for NIDDM in urban Africans in Cape Town, South Africa. Diabetes Care. 1993;16(4):601-607.
20. Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. NEJM. 1998;339:1957-1963.
21. Ware JE, Gandek B. Methods for testing data quality, scaling assumptions, and reliability: The IQOLA Project Approach. J Clin Epidemiol. 1998;51(11):945-952.